Dicerna Pharmaceuticals
DRNA
Rank
3734
Country
USA
Exchange
NASDAQ
Currency
USD
Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Address
33 HAYDEN AVENUE, LEXINGTON, MA, US
Dicerna Pharmaceuticals - Key figures
Market cap
2.98 Billion
Revenue
192.85 Million
Profit
-41,077,000
P/E Ratio
No information
P/s Ratio
15.44
Dicerna Pharmaceuticals - Description
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceuticals based on ribonucleic acid (RNAi) interference.
The company is headquartered in Lexington, Massachusetts.